BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jomrich G, Hollenstein M, John M, Baierl A, Paireder M, Kristo I, Ilhan-Mutlu A, Asari R, Preusser M, Schoppmann SF. The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction. Oncotarget 2018;9:6968-76. [PMID: 29467943 DOI: 10.18632/oncotarget.24087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kudou K, Kusumoto T, Nambara S, Tsuda Y, Kusumoto E, Yoshida R, Sakaguchi Y, Ikejiri K. New index combining multiple inflammation‐based prognostic scores for predicting the prognosis of gastric cancer patients. JGH Open. [DOI: 10.1002/jgh3.12723] [Reference Citation Analysis]
2 Kudou K, Saeki H, Nakashima Y, Kamori T, Kawazoe T, Haruta Y, Fujimoto Y, Matsuoka H, Sasaki S, Jogo T, Hirose K, Hu Q, Tsuda Y, Kimura K, Ando K, Oki E, Ikeda T, Maehara Y. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. J Gastroenterol Hepatol. 2019;34:355-363. [PMID: 30119141 DOI: 10.1111/jgh.14442] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
3 Liu CT, Hong CQ, Huang XC, Li EM, Xu YW, Peng YH. Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer. J Cancer 2020;11:4332-42. [PMID: 32489452 DOI: 10.7150/jca.44545] [Reference Citation Analysis]
4 Ludwig JM, Haubold J, Bauer S, Richly H, Siveke JT, Wimmer J, Umutlu L, Schaarschmidt BM, Theysohn JM. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion. Radiol Oncol 2021;55:347-53. [PMID: 34051707 DOI: 10.2478/raon-2021-0027] [Reference Citation Analysis]
5 Qi F, Xu Y, Zheng Y, Li X, Gao Y. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis. Ann Transl Med 2019;7:531. [PMID: 31807513 DOI: 10.21037/atm.2019.09.160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 Hank T, Sandini M, Ferrone CR, Rodrigues C, Weniger M, Qadan M, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy. JAMA Surg 2019;154:943-51. [PMID: 31411659 DOI: 10.1001/jamasurg.2019.2272] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
7 Brown JT, Liu Y, Shabto JM, Martini D, Ravindranathan D, Hitron EE, Russler GA, Caulfield S, Yantorni L, Joshi SS, Kissick H, Ogan K, Nazha B, Carthon BC, Kucuk O, Harris WB, Master VA, Bilen MA. Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. J Immunother Cancer 2021;9:e002851. [PMID: 34326170 DOI: 10.1136/jitc-2021-002851] [Reference Citation Analysis]
8 Pitre T, Jones A, Su J, Helmeczi W, Xu G, Lee C, Shamsuddin A, Mir A, MacGregor S, Duong M, Ho T, Beauchamp MK, Costa AP, Kruisselbrink R; COREG Investigators. Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study. Intern Emerg Med 2021;16:1573-82. [PMID: 33496923 DOI: 10.1007/s11739-021-02637-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. J Gastrointest Surg. 2020;24:610-618. [PMID: 30923999 DOI: 10.1007/s11605-019-04187-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
10 Cao J, Luo F, Zeng K, Ma W, Lu F, Huang Y, Zhang L, Zhao H. Predictive Value of High Preoperative Serum Total Protein and Elevated Hematocrit in Patients with Non-Small-Cell Lung Cancer after Radical Resection. Nutr Cancer 2022;:1-13. [PMID: 35642624 DOI: 10.1080/01635581.2022.2079683] [Reference Citation Analysis]
11 Kheirouri S, Alizadeh M. Prognostic Potential of the Preoperative Controlling Nutritional Status (CONUT) Score in Predicting Survival of Patients with Cancer: A Systematic Review. Adv Nutr 2021;12:234-50. [PMID: 32910812 DOI: 10.1093/advances/nmaa102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
12 Kudou K, Kusumoto T, Ebata Y, Nambara S, Tsuda Y, Kusumoto E, Yoshida R, Sakaguchi Y, Ikejiri K. Prediction of hospital mortality after colorectal perforation surgery from inflammation-based prognostic scores. Surgery Open Science 2022. [DOI: 10.1016/j.sopen.2022.01.003] [Reference Citation Analysis]
13 Zheng R, Wang O, Bradley E, Lavu H, Winter JR, Rosato EL, Palazzo F, Yeo CJ, Berger AC. Minimally Invasive Distal Pancreatectomy Is Associated with Decreased Postoperative Neutrophil to Lymphocyte Ratio. J Pancreat Cancer 2020;6:32-9. [PMID: 32462109 DOI: 10.1089/pancan.2019.0020] [Reference Citation Analysis]
14 Hiraoka SI, Shimada Y, Kawasaki Y, Akutagawa M, Tanaka S. Preoperative nutritional evaluation, surgical site infection, and prognosis in patients with oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2022:S2212-4403(22)00009-8. [PMID: 35430178 DOI: 10.1016/j.oooo.2022.01.009] [Reference Citation Analysis]
15 Ikuta S, Aihara T, Yamanaka N. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma. Asia Pac J Clin Oncol 2019;15:e109-14. [PMID: 30632282 DOI: 10.1111/ajco.13123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Schoppmann SF. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Ann Surg 2021;273:532-41. [PMID: 31425286 DOI: 10.1097/SLA.0000000000003370] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
17 Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, Asari R, Schoppmann SF. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma. Ann Surg Oncol 2019;26:976-85. [PMID: 30706229 DOI: 10.1245/s10434-019-07186-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lorton CM, Higgins L, O'Donoghue N, Donohoe C, O'Connell J, Mockler D, Reynolds JV, Walsh D, Lysaght J. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis. Ann Surg Oncol 2021. [PMID: 34773194 DOI: 10.1245/s10434-021-10988-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]